Institutional Ownership Aim Immuno Tech Inc. (AIM)
This table provides information about the institutional ownership of Aim Immuno Tech Inc. (AIM). We have compiled data on the 5 institutions that hold shares in the stock, with a total of 699,149 shares, which have been reported (via 13F filing form) to have a value of $1.76 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
698,267
shares
|
$1.82 Million
0.0% of portfolio
|
Q2 2024
Reduced 0.01%
|
|
|
Cordasco Financial Network
|
Jul 15, 2022 Q2 2022 |
500
shares
|
$1,300
0.0% of portfolio
|
Q1 2022
New holding
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
228
shares
|
$592
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
127
shares
|
$330
0.0% of portfolio
|
Q1 2025
Reduced 7.97%
|
|
|
Mai Capital Management
|
May 15, 2025 Q1 2025 |
27
shares
|
$70
0.0% of portfolio
|
Q4 2024
New holding
|